Combination Therapy of HAIC, Surufatinib and Tislelizumab for Unresectable or Metastatic Biliary Tract Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Eastern Hepatobiliary Surgery Hospital
Charite University, Berlin, Germany
Peking Union Medical College Hospital
Tianjin Medical University Cancer Institute and Hospital
Sun Yat-sen University
RenJi Hospital
Yonsei University
Tianjin Medical University Cancer Institute and Hospital
Shanghai Jiao Tong University School of Medicine
Shanghai Jiao Tong University School of Medicine
Leaf Vertical Inc.
Shanghai Jiao Tong University School of Medicine
Tongji Hospital
Fudan University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Simcere Pharmaceutical Co., Ltd
Charite University, Berlin, Germany